Carl Byrnes
Stock Analyst at Northland Securities
(0.26)
# 4,200
Out of 4,376 analysts
306
Total ratings
36.9%
Success rate
-4.1%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTB Connect Biopharma Holdings | Maintained: Buy | $7.5 | $2.17 | +245.62% | 3 | Apr 24, 2026 | |
| MDXG MiMedx Group | Maintained: Buy | $10 → $6 | $3.74 | +60.43% | 27 | Apr 17, 2026 | |
| SPRY ARS Pharmaceuticals | Maintained: Buy | $25 | $8.56 | +192.06% | 2 | Apr 15, 2026 | |
| RCEL AVITA Medical | Maintained: Buy | $10 | $4.18 | +139.23% | 2 | Mar 26, 2026 | |
| BLFS BioLife Solutions | Reiterated: Buy | $34 | $26.65 | +27.58% | 37 | Mar 24, 2026 | |
| TLSI TriSalus Life Sciences | Rated: Buy | $13 → $8 | $3.17 | +152.37% | 5 | Mar 23, 2026 | |
| MDAI Spectral AI | Maintained: Buy | $6 | $1.89 | +217.46% | 12 | Mar 19, 2026 | |
| SNWV SANUWAVE Health | Maintained: Buy | $55 | $14.76 | +272.63% | 4 | Mar 16, 2026 | |
| BWAY BrainsWay | Maintained: Buy | $12 → $15 | $13.89 | +7.99% | 14 | Jan 22, 2026 | |
| ALVO Alvotech | Maintained: Buy | $10 | $3.54 | +182.49% | 18 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $4 | $0.4274 | +835.89% | 39 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.6585 | +659.30% | 4 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $3.13 | n/a | 34 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $2 → $1.25 | $13.93 | n/a | 12 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.96 | n/a | 1 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 → $1 | $0.0001 | n/a | 24 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $2 | $0.0002 | n/a | 24 | Nov 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $2 | $32.14 | n/a | 30 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.25 | n/a | 12 | May 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $57.27 | n/a | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $14.44 | n/a | 1 | Oct 22, 2018 |
Connect Biopharma Holdings
Apr 24, 2026
Maintained: Buy
Price Target: $7.5
Current: $2.17
Upside: +245.62%
MiMedx Group
Apr 17, 2026
Maintained: Buy
Price Target: $10 → $6
Current: $3.74
Upside: +60.43%
ARS Pharmaceuticals
Apr 15, 2026
Maintained: Buy
Price Target: $25
Current: $8.56
Upside: +192.06%
AVITA Medical
Mar 26, 2026
Maintained: Buy
Price Target: $10
Current: $4.18
Upside: +139.23%
BioLife Solutions
Mar 24, 2026
Reiterated: Buy
Price Target: $34
Current: $26.65
Upside: +27.58%
TriSalus Life Sciences
Mar 23, 2026
Rated: Buy
Price Target: $13 → $8
Current: $3.17
Upside: +152.37%
Spectral AI
Mar 19, 2026
Maintained: Buy
Price Target: $6
Current: $1.89
Upside: +217.46%
SANUWAVE Health
Mar 16, 2026
Maintained: Buy
Price Target: $55
Current: $14.76
Upside: +272.63%
BrainsWay
Jan 22, 2026
Maintained: Buy
Price Target: $12 → $15
Current: $13.89
Upside: +7.99%
Alvotech
Nov 14, 2025
Maintained: Buy
Price Target: $10
Current: $3.54
Upside: +182.49%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $4
Current: $0.4274
Upside: +835.89%
Aug 28, 2025
Maintained: Buy
Price Target: $5
Current: $0.6585
Upside: +659.30%
May 8, 2024
Maintained: Hold
Price Target: $3
Current: $3.13
Upside: n/a
Jul 19, 2023
Rated: Hold
Price Target: $2 → $1.25
Current: $13.93
Upside: n/a
May 22, 2023
Initiated Coverage: Buy
Price Target: $8
Current: $1.96
Upside: n/a
Jan 6, 2023
Downgraded: Sell
Price Target: $8 → $1
Current: $0.0001
Upside: n/a
Nov 23, 2022
Maintained: Buy
Price Target: $10 → $2
Current: $0.0002
Upside: n/a
Aug 17, 2022
Maintained: Buy
Price Target: $4 → $2
Current: $32.14
Upside: n/a
May 14, 2020
Rated: Hold
Price Target: n/a
Current: $2.25
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: $45
Current: $57.27
Upside: n/a
Oct 22, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $14.44
Upside: n/a